FDA Clearance Tracker · P190030-S004
ActaStim-S
Last checked: Nov 20, 2026Latest source record: May 13, 2026 (this decision)Source: openFDAMethods & limitations
Decided
May 13, 2026
Approved
Time to decision
499 days
Received Dec 30, 2024. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class II
The decision
- FDA number
- P190030-S004
- Device name
- ActaStim-S
- Applicant
- Theragen, Inc.
- Applicant location
- Manassas, VA
- Received
- Dec 30, 2024
- Decided
- May 13, 2026
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Labeling Change - Indications/instructions/shelf life/tradename
- Original approval
- P190030
Device type
- Device type
- Stimulator, bone growth, non-invasive (LOF)
- Device class
- Class II
- Regulation
- 21 CFR 890.5870
- Specialty
- Orthopedic Surgery
FDA's approval statement
As written in FDA's record.
Approval for allowance for reconditioning of the ActaStim-S Spine Fusion Stimulator.
Source documents
Other decisions for Theragen, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P190030 · Decided Dec 9, 2020 · 387 days after receipt
Device type: Stimulator, bone growth, non-invasive (LOF) · Orthopedic Surgery
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.